Centanafadine sustained-release (CTN SR)

centanafadine · Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Centanafadine sustained-release (CTN SR), covering 2021-11-11 to 2021-11-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 2]

See pricing